SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Activity
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

25 hedge funds and large institutions have $3.66M invested in Seelos Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 10 closing their positions.

Holders
25
Holders Change
-5
Holders Change %
-16.67%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
4
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.5M
2
BlackRock
2
BlackRock
New York
$541K
3
MWP
3
MYCIO Wealth Partners
Pennsylvania
$41K
4
UIC
4
Uniplan Investment Counsel
Wisconsin
$890K
5
PA
5
Procyon Advisors
Connecticut
$3K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
WS
2
Wedbush Securities
California
$0
3
VF
3
Virtu Financial
New York
$0
4
ARTA
4
A.R.T. Advisors
New York
$0
5
CH
5
CVI Holdings
Delaware
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
26
Group One Trading
Illinois
$0 17 – –
UBS Group
27
UBS Group
Switzerland
$0 1 – –
HI
28
Hudock Inc
Pennsylvania
$0 1 – –
Wells Fargo
29
Wells Fargo
California
$0 33 – –
AG
30
Advisor Group
Arizona
$0 18 – –
LFG
31
Larson Financial Group
Missouri
$0 2 – –
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
$0 16 – –
CFGS
33
Concourse Financial Group Securities
Alabama
– – – –
Barclays
34
Barclays
United Kingdom
$0 1 +1 New
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$0 3 +3 New
HWM
36
Howard Wealth Management
Connecticut
$0 50 +50 New
1
2